SeouLin Bioscience to Distribute Cellular Dynamics’ Products in Korea
MADISON, Wis. Cellular Dynamics International, Inc. (CDI), a FUJIFILM company, today announced an exclusive agreement with SeouLin Bioscience Co., Ltd., for the distribution of CDI’s products in the...
View ArticleBig Changes for Medtech in First Half of 2015 While Pharma Set To Break Records
LONDON & BOSTON & TOKYO The first half of 2015 has continued to confound the naysayers of the pharma industry, with deal making, venture funding and share price indices all going strong....
View Article2015 Q2 Life Sciences Hiring Index Remains near Historical High
ROCHELLE PARK, N.J. ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. Hiring levels were at their highest levels yet for both the Pharma and Biotech...
View ArticleTakeda Announces European Medicines Agency Acceptance of Ixazomib’s Marketing...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application...
View ArticleVerdeca’s HB4 Stress Tolerance Trait Completes US Food and Drug...
DAVIS, Calif. & ROSARIO, Argentina Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Bioceres S.A. announced today that Verdeca, their soybean technology joint venture, received notification that the...
View ArticleTakeda and Nanotherapeutics Announce Agreement to Expand Takeda’s...
ALACHUA, Fla. & OSAKA, Japan Takeda Pharmaceutical Company Limited (Takeda) (TOKYO: 4502) and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and...
View ArticleAdare Pharmaceuticals、ジョセフ・デルブオノを財務担当副社長兼最高財務責任者に任命
米ニュージャージー州プリンストン (ビジネスワイヤ) — Adare Pharmaceuticals(旧アプタリス・ファーマシューティカル・テクノロジーズ)は本日、ジョセフ(ジョー)・デルブオノが財務担当副社長兼最高財務責任者(CFO)として入社したと発表しました。デルブオノは、当社のニュージャージー州プリンストンの本社を拠点に活動します。 Adare PharmaceuticalsのJohn...
View Article美国食品药品管理局完成Verdeca的HB4耐应激性状的早期食品安全性评估
加州戴维斯和阿根廷罗萨里奥 (美国商业资讯)–Arcadia Biosciences, Inc. (NASDAQ: RKDA)和Bioceres...
View ArticleTransgenomic Adds Asia Distributors for Its ICEme™ Kits That Enable Liquid...
OMAHA, Neb. Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced the...
View ArticlePrana Reports FY15 Financial Results
MELBOURNE, Australia Prana Biotechnology Limited (ASX:PBT) (NASDAQ:PRAN) yesterday announced its financial results for the 12 months to June 30, 2015. Financial Results Full year revenue of...
View ArticleDr. Reddy’s Announces Management Changes
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) today announced the following senior level changes in their global management structure. Umang Vohra is moving out of the organization and has...
View ArticleAsia’s Largest Business Partnering Event- Biotech Industry Key Players from...
TOKYO BioJapan 2015 will be held for three days from October 14th (Wed) to 16th (Fri), 2015 at Pacifico Yokohama. This Smart News Release features multimedia. View the full release here:...
View Article亚洲最大的业务洽谈盛会——来自30个国家的生物科技产业重要企业将齐聚BioJapan 2015!
东京 (美国商业资讯)–为期三天的BioJapan 2015将于10月14日(周三)至16日(周五)在横滨太平洋会展中心(Pacifico Yokohama)举行。 Smart News Releases(智能新闻稿)是一个多媒体平台。在此处查看完整新闻稿: http://www.businesswire.com/news/home/20150827005015/zh-CN/ BioJapan...
View Article30ヶ国よりバイオ産業の最前線キープレーヤーが集結!アジア最大級のパートナリングイベントBioJapan 2015開催
東京 (ビジネスワイヤ) — 来る2015年10月14日(水)~16日(金)の3日間、パシフィコ横浜の展示ホールC・Dとアネックスホール全館においてBioJapan 2015 を開催します。 このSmart News Release(スマート・ニュース・リリース)にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから:...
View ArticleH.Lundbeck A/S: Experts Call for Urgent Action to Better Diagnose Severe Form...
LONDON A new report launched today, ‘Paying the ultimate price’, highlights the urgent need for accurate diagnosis and management of bipolar I disorder in order to address a significant burden on...
View ArticleUS FDA Approves Initiation of ViroMed’s VM202 for Phase III Clinical Study of...
ATLANTA ViroMed Co., Ltd. (084990:KS, KOSDAQ) today announced that the company has received an approval from the US FDA to launch a pivotal Phase III clinical trial utilizing VM202, a proprietary...
View Article大日本住友製薬との共同研究における最初のマイルストーン達成に関するお知らせ
スコットランド・ダンディー ex scientia Ltd.(以下、「エクセンシア」)は大日本住友製薬株式会社(以下、「大日本住友製薬」)との初年度の共同研究において、高次評価試験を進めるに値する最適化化合物を取得したことを発表します。...
View ArticleASE Foundation Selects Mindray as Exclusive Corporate Sponsor of Its...
HA NOI, Vietnam Mindray, one of the world’s leading developers of cardiac ultrasound technologies, is proud to announce that it was exclusively selected for the American Society of Echocardiography...
View ArticleNovaBay Pharmaceuticals Signs Distribution Agreement to Make Avenova...
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care...
View Article